Congenix Adds Russian Presence to Agile Clinical Network

CRO based in Moscow joins HD's worldwide network of research organizations dedicated to maximizing the efficiency of global trials

Health Decisions welcomes Moscow-based CRO Congenix to the Agile Clinical Network—a community of research partners formed to eliminate the information gaps and prolonged timelines inherent to complex global studies. Congenix joins a group of like-minded CROs employing Agile Clinical Development—Health Decisions’ method of combining adaptive design and adaptive operations—in a drive to cut timelines and increase transparency for multinational trials.

Congenix completed an in-depth training program that covers every aspect of Agile Clinical Development, focusing especially on adaptive operations and infrastructure. This training is mandatory for all Network members, and ensures that all CROs operating in the Network adhere to the same stringent standards and guidelines.

According to Dr. Vladimir V. Novakovskiy, managing director, Clinical Operations and Regulatory Affairs at Congenix, Eastern Europe and Russia offer sponsors high recruitment rates, an excellent selection of high-quality investigational sites, and lower cost per patient compared to Western Europe and the U.S. Other benefits include Russia’s highly centralized healthcare system and a large percentage of treatment-naïve patients. 

Quotes

“Conducting global, multi-center trials with a network of regionally focused CROs offers many advantages over a single large CRO with international offices. We look forward to bringing our extensive knowledge of Eastern Europe and Russia to the Agile Clinical Network to better assist sponsors with assessing investigators, cooperating with the local regulatory bodies, and recruiting study subjects.”

- Vladimir V. Novakovskiy, M.D., Ph.D., managing director, Clinical Operations and Regulatory Affairs, Congenix, LLP

“We welcome Congenix to the Agile Clinical Network and look forward to our working together on global trials that will maximize efficiency and transparency. Congenix will be a great asset to our Network as we expand its mission to deliver accurate trial results on an accelerated timeline, regardless of where a study is run.”

- Rick Farris, COO, Health Decisions

A UK-registered CRO with offices in Moscow and Hercules, CA, USA, Congenix offers Phase I to IV services including regulatory affairs, clinical monitoring, project management, investigational site management, study supplies custom clearance, warehousing and distribution. Working within the Agile network, Congenix will have access to Health Decisions’ and other members’ high-efficiency data management systems, biostatistics expertise, medical writers, advanced data collection tools, and real-time reporting capabilities, as well as regional infrastructure around the world.

For more information: contact Kate Hendrick, Marketing Specialist, +1.919.967.1111 x116. To learn more about the Agile Clinical Network, see the press release announcing its formation, or read about the certification processes and prequalification requirements here.

About Congenix

Congenix (www.congenix.com) is a U.K. registered independent contract research organization (CRO) with expertise in conducting clinical trials in Russia and Eastern Europe. The company offers its clients a full range of services, using cutting-edge technology to provide high-quality results, on time and on budget.

###